These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29423674)

  • 1. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice.
    Hashemi SM; Hassan ZM; Hossein-Khannazer N; Pourfathollah AA; Soudi S
    Inflammopharmacology; 2020 Apr; 28(2):585-601. PubMed ID: 31741175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
    Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
    Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice.
    Ho JH; Tseng TC; Ma WH; Ong WK; Chen YF; Chen MH; Lin MW; Hong CY; Lee OK
    Cell Transplant; 2012; 21(5):997-1009. PubMed ID: 22004871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose Tissue-Derived Mesenchymal Stromal Cells Modulate Inflammatory Response and Improve Allograft Islet Transplant in Mice Model of Type 1 Diabetes.
    Niknam B; Ayenehdeh JM; Hossein-Khannazer N; Vosough M; Tajik N
    Endocr Res; 2024; 49(4):223-231. PubMed ID: 38982737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
    Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
    Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus.
    Li L; Li F; Gao F; Yang Y; Liu Y; Guo P; Li Y
    Cell Tissue Res; 2016 May; 364(2):345-55. PubMed ID: 26650464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H; Hashemi SM; Soleimani M; Mohammadi J; Tajik N
    J Diabetes Res; 2015; 2015():878535. PubMed ID: 25893202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
    Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transplantation of mesenchymal stem cells induced into early hepatic cells in streptozotocin-induced diabetic mice.
    Dinarvand P; Hashemi SM; Soleimani M
    Biol Pharm Bull; 2010; 33(7):1212-7. PubMed ID: 20606315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
    Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
    Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
    Bao Y; Zhao Z; Gao H
    Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.